Will Danaher's (DHR) AI Push and Tariff Tailwinds Reinforce Its Recurring Revenue Narrative?
... risks . The recent launch of Leica Biosystems' AI -powered pathology solutions may positively support Danaher's short-term narrative around product ...
Read the original at Simply Wall St ↗
- Tracked via
- “AI Risks”